lynch, HNPCC syndrome
Li Fraumeni syndrome
Cowden Disease
capacity to make decisison (suggested guideliens)
women who have a 20-25%+ risk of breast and ovarian cancer due to familiar risk include;
women who have 5-10% risk breast/ovarian cancer include those with:
paraneoplastic syndromes from ovarian disease
GTN WHO scoring
review the photo for a general idea
pharmacologic ppx anticoaguation preferneces in surgery
risk factors for PE well criteria and imaging to dx
CT angio is how you diagnose for everyoene (not ddimer, VQ scan etc)
tamoxifen
women >30yo with breast mass need what work up
- (MRI only helpful in women with breast implants, very dense breast tissue, lots of breast scaring from prior surgery)
gas embolism
bowel obstruction with cancer
necrotizing fasciitis symptmos
non-cancer breast diagnosis
gynecological hemorrhage
1000mL QBL or any QBL that requires transfusion
hcg levels in peri/postmenopausal women elevated <14
- suppress with OCPs, shoudl go down, and then recheck hcg levels
ovarian cacner with bowel involvement: surgical extent
AGC finding on pap requires what additional testing
- if >35 then ECC and Embx and colpo
when to pause chemo treatments based on lab values
Granulocysts
Platelets
psuedomyxoma peritonei
anemia panel findings and meaning
*note that EPO and associated meds (darbopoein) are contraindicated beause of an association of cancer progressoin
some immunostaining markers to help tell cancers apart: CK7 KRT7 CA 125 PAX8 WT1 KRT 20 CK20 CEA CDX2 Vementin
SErous ovarian tumors CK7 KRT7 CA 125 PAX8 WT1
Gatsrointestintal tumors KRT 20 CK20 CEA CDX2
negative vinmentin: no endometiral or ovarian